1. Home
  2. BNED vs OBIO Comparison

BNED vs OBIO Comparison

Compare BNED & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barnes & Noble Education Inc

BNED

Barnes & Noble Education Inc

N/A

Current Price

$12.46

Market Cap

440.9M

ML Signal

N/A

OBIO

Orchestra BioMed Holdings Inc.

N/A

Current Price

$7.11

Market Cap

473.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BNED
OBIO
Founded
1965
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
440.9M
473.0M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
BNED
OBIO
Price
$12.46
$7.11
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
★ $17.25
$13.14
AVG Volume (30 Days)
147.9K
★ 458.7K
Earning Date
12-08-2026
11-10-2026
Dividend Yield
★ 2.49%
N/A
EPS Growth
★ 119.60
33.13
EPS
★ N/A
N/A
Revenue
★ $1,714,770,000.00
$33,482,000.00
Revenue This Year
$2.88
N/A
Revenue Next Year
N/A
$52.64
P/E Ratio
★ N/A
N/A
Revenue Growth
6.50
★ 1169.22
52 Week Low
$5.90
$3.46
52 Week High
$14.75
$7.45

Technical Indicators

Market Signals
Indicator
BNED
OBIO
Relative Strength Index (RSI) 46.99 61.74
Support Level $11.55 $3.81
Resistance Level $13.11 N/A
Average True Range (ATR) 0.48 0.57
MACD -0.09 0.15
Stochastic Oscillator 21.10 70.46

Price Performance

Historical Comparison
BNED
OBIO

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is contract operators of physical and virtual bookstores for college and university campuses and K-12 institutions across the United States. The company is also one of the textbook wholesalers and inventory management hardware and software providers The company operates physical and virtual bookstores that delivers essential educational content and general merchandise within a dynamic omnichannel retail environment. The Company currently operates as a single operating and reporting segment. The company's solutions are Academic Solutions, College Retail Solutions, College Insights, Wholesale & Store Technology Services.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

Share on Social Networks: